NASDAQ:TNDM - Tandem Diabetes Care Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $28.45 -1.59 (-5.29 %) (As of 11/20/2018 04:00 PM ET)Previous Close$30.04Today's Range$26.40 - $30.4952-Week Range$2.14 - $52.55Volume2.07 million shsAverage Volume2.42 million shsMarket Capitalization$1.92 billionP/E Ratio-2.21Dividend YieldN/ABeta0.53 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Tandem Diabetes Care (NASDAQ:TNDM) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.12 Wall Street analysts have issued ratings and price targets for Tandem Diabetes Care in the last 12 months. Their average twelve-month price target is $44.6250, suggesting that the stock has a possible upside of 56.85%. The high price target for TNDM is $60.00 and the low price target for TNDM is $5.50. There are currently 3 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.752.752.892.86Ratings Breakdown: 0 Sell Rating(s)3 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)3 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)1 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)1 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $44.6250$44.0417$30.50$9.9167Price Target Upside: 56.85% upside21.43% upside15.11% downside22.71% downsideTandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails11/9/2018OppenheimerSet Price TargetBuy$57.00Medium11/3/2018Lake Street CapitalSet Price TargetBuy$60.00High11/2/2018Craig HallumSet Price TargetBuy$59.00High9/26/2018Dougherty & CoBoost Price TargetBuy$45.00 ➝ $56.00Low9/26/2018Piper Jaffray CompaniesReiterated RatingAbove Average ➝ Overweight$32.00 ➝ $56.00Medium9/14/2018Robert W. BairdDowngradeOutperform ➝ NeutralMedium9/5/2018MEDBoost Price TargetOutperform$38.00 ➝ $54.00High8/30/2018Berenberg BankInitiated CoverageBuy ➝ Buy$50.00High8/24/2018Bank of AmericaUpgradeUnderperform ➝ Neutral$45.00High8/22/2018Stifel NicolausInitiated CoverageHold$25.00 ➝ $34.00High7/31/2018CowenReiterated RatingBuy$28.00High2/27/2018CitigroupInitiated CoverageOutperform$5.50Low10/10/2017WedbushReiterated RatingOutperform$50.00 ➝ $17.00N/A5/3/2017B. RileyReiterated RatingNeutral$15.00Medium3/9/2017Northcoast ResearchReiterated RatingBuyN/A(Data available from 11/20/2016 forward) This page was last updated on 11/20/2018 by MarketBeat.com StaffFeatured Article: What does cost of debt say about a company’s financial health?